BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1283511)

  • 21. Quantitation of antigens in normal and malignant ovarian tissue.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1975 Oct; 123(3):302-4. PubMed ID: 1180293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers.
    Higashi H; Nishi Y; Fukui Y; Ikuta K; Ueda S; Kato S; Fujita M; Nakano Y; Taguchi T; Sakai S
    Gan; 1984 Nov; 75(11):1025-9. PubMed ID: 6394416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of gangliosides as N-glycolylneuraminic acid-specific tumor-associated Hanganutziu-Deicher antigen in human retinoblastoma cells.
    Higashi H; Sasabe T; Fukui Y; Maru M; Kato S
    Jpn J Cancer Res; 1988 Aug; 79(8):952-6. PubMed ID: 2460424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of biotinylated antibody for the assay of Hanganutziu-Deicher antibodies and antigens in fluids and tissues from cancer patients.
    Gathuru JK; Higashi H; Kato S; Usuba O; Naiki M
    Jpn J Vet Res; 1989 Apr; 37(2):71-83. PubMed ID: 2789305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
    Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
    Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Heterophile" antigen in sera of human recipients of renal allografts.
    Milgrom F; Loza U; Czechowski D; Kasukawa R; Anthone R; Anthone S
    Proc Soc Exp Biol Med; 1996 Oct; 213(1):80-4. PubMed ID: 8820827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
    Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers.
    Hirabayashi Y; Kasakura H; Matsumoto M; Higashi H; Kato S; Kasai N; Naiki M
    Jpn J Cancer Res; 1987 Mar; 78(3):251-60. PubMed ID: 3106281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potential radioimmunoassay system for detection of Hanganutziu-Deicher type heterophile antigen(s) and antibodies in tissues and fluids.
    Mukuria JC; Naiki M; Hashimoto M; Nishiura K; Okabe M; Kato S
    J Immunol Methods; 1985 Jun; 80(1):97-106. PubMed ID: 3874240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian tumor antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1978 Sep; 42(3 Suppl):1616-20. PubMed ID: 81712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on xenogenic antisera to tumor-associated antigen of ovarian carcinoma.
    Gerber MA; Faiferman I; Cohen CJ; Koffler D
    Clin Immunol Immunopathol; 1977 Sep; 8(2):171-80. PubMed ID: 198173
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.